Technology · 49 views

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

Source Summary Published July 20, 2026 Brief Under 1 min brief

Story intelligence

Coverage Single outlet Single-outlet story

Views 49 Community interest

Brief read Under 1 min brief 16 words

Summary

The de-extinction startup is looking to double or triple its previous valuation, according to the report.

Read original at TechCrunch

Coverage Context

Part of 20B coverage 11 tracked stories

Explore 20B View timeline

WIRED6m ago3 views
Anthropic Flags Gas Supply as One of Its Biggest Near-Term RisksContinue reading
WIRED26m ago8 views
Early Black Friday Deals 2026Continue reading
The Verge55m ago8 views
VisionQuest is what happens when AI really goes rogueContinue reading
GeekWire1h ago4 views
Seattle’s Kivo Health raises $10M to bring lung disease rehab into patients’ homesContinue reading

Support HappeningNow

Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.

Support HappeningNow

Report an issue with this page

HAPPENING NOW

Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

Coverage Context

More from Technology